Retreatment of Recurrent Carcinoma of the Head and Neck by Afterloading Interstitial 192IR Implant
Retreatment of Recurrent Carcinoma of the Head and Neck by Afterloading Interstitial 192IR Implant
复制标题
后装间质 192IR 植入物再治疗头颈复发癌
DOI：
--
复制
发表时间：
1983
期刊：
影响因子：
--
通讯作者：
J. Marks
中科院分区：
文献类型：
--
作者：
B. Emami;J. Marks
从1975年1月至1980年12月，25例持续或复发的头颈部癌患者在Mallinckrodt放射学研究所放射肿瘤科接受姑息治疗。这些患者均接受过广泛的手术和/或放疗治疗。所有患者均再次接受192 Ir组织间植入治疗，伴或不伴外照射和/或手术切除。在25例患者中，13例完全缓解（CR），6例部分缓解，随访期为1 - 7年。在13例CR患者中，6例存活但无疾病证据（NED），2例死亡。我们提出了详细的结果，并讨论了我们的新策略，这样的病人。
From January 1975 to December 1980, 25 patients with persistent or recurrent carcinomas of the head and neck were retreated for palliation at the Division of Radiation Oncology, Mallinckrodt Institute of Radiology. These patients had all undergone extensive previous treatment by surgery and/or radiation. All were retreated with 192Ir interstitial implant with or without external radiation and/or surgical excision. Of 25 patients, 13 had complete response (CR) and 6 had partial response for a follow‐up period of 1 to 7 years. Of 13 patients with CR, 6 are alive with no evidence of disease (NED) and two died NED. We present detailed results and discuss our new strategy for such patients.